Imaging of Chemotherapy-induced Morphological and Functional Lung Changes in Childhood ALL and HD
Conditions: Acute Lymphoblastic Leukemia; Hodgkin Disease; Allogeneic Stem Cell Transplantation Interventions: Diagnostic Test: Low-field magnetic resonance imaging; Diagnostic Test: Cardiopulmonary testing; Diagnostic Test: Pulmonary testing; Diagnostic Test: Blood sample Sponsors: University of Erlangen-N ürnberg Medical School Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 20, 2023 Category: Research Source Type: clinical trials
A Study to Evaluate Mesenchymal Stem Cell Product StromaForte's Effect on Cardiovascular Events
Conditions: Cardiovascular Diseases Interventions: Biological: Human Allogeneic Bone-Marrow-Derived Mesenchymal Stromal Cell Product (StromaForte) Sponsors: Cellcolabs Clinical LTD. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 18, 2023 Category: Research Source Type: clinical trials
Psychological Impact of Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation on Donors
Conditions: Haplo-identical Transplantation; Transplantation Interventions: Other: Evaluate the evolution of the psychic state of the donors (ascendants and descendants), by means of questionnaires, within the framework of haplo-identical allograft. Sponsors: Assistance Publique - H ôpitaux de Paris Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 18, 2023 Category: Research Source Type: clinical trials
Study on the Safety and Tolerance of Mesenchymal Stem Cells Mediated by Arthroscopy in Patients With Osteoarthritis
Conditions: Osteoarthritis, Knee Interventions: Biological: Human Umbilical Mesenchymal Stem Cells Sponsors: First Affiliated Hospital of Wannan Medical College Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 13, 2023 Category: Research Source Type: clinical trials
Phase III Study Comparing GVHD Prophylaxis With ATG-thymoglobulin to ATLG-grafalon in Elderly Patients With Acute Myeloid Leukemia or Myelodysplasic Syndrome and Receiving an Allogeneic Hematopoietic Stem Cell Transplantation With a 10/10 HLA Matched Unrelated Donor
Conditions: GVHD Interventions: Drug: Grafalon; Drug: Thymoglobulin Sponsors: Assistance Publique - H ôpitaux de Paris Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 13, 2023 Category: Research Source Type: clinical trials
αβT Cell/CD19+ B Cell Depletion for Alternative Donor Allogeneic Hematopoietic Cell Transplantation (HSCT)
Conditions: Hematopoietic Stem Cell Transplantation; Hematologic Malignancy Interventions: Device: CliniMACS ® Sponsors: Nationwide Children ' s Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 13, 2023 Category: Research Source Type: clinical trials
Tacrolimus Blood Concentration and Transplant-related Outcomes in Pediatric HSCT Recipients
Conditions: Graft Vs Host Disease; Transplant Failure; Stem Cell Transplant Complications Interventions: Drug: TAC C/D ratio Sponsors: University of Pisa Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 12, 2023 Category: Research Source Type: clinical trials
Siplizumab for Sickle Cell Disease Transplant
Conditions: Anemia, Sickle Cell Interventions: Drug: Siplizumab; Procedure: Exchange Transfusion; Procedure: Total Body Irradiation; Procedure: Stem Cell Infusion; Drug: Cyclophosphamide 50mg; Drug: Mesna; Drug: Sirolimus Oral Tablet; Drug: Rituximab or Biosimilar Sponsors: Markus Mapara; ITB-Med LLC Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 12, 2023 Category: Research Source Type: clinical trials
Muscle Stem Cell Quality in Atrophy
Conditions: Muscle Weakness; Atrophy, Muscle; Cachexia; Sarcopenia; Stem Cell Transplantation; Mesenchymal Stem Cells Interventions: Other: In vitro analyse Sponsors: Maastricht University Medical Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 11, 2023 Category: Research Source Type: clinical trials
Mechanisms of Treatment Effects Using Cultured, Allogeneic Mesenchymal Stromal Stem Cells (MSCs) in Knee Osteoarthritis
Conditions: Osteoarthritis, Knee Interventions: Biological: Knee aspiration + UCB-MSCs; Other: Knee aspiration Sponsors: University Medical Centre Ljubljana; Blood Transfusion Centre of Slovenia Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 11, 2023 Category: Research Source Type: clinical trials
Total Lymphoid Irradiation as Conditioning for Pediatric Haploidentical Hematopoietic Stem Cell Transplantation
Conditions: Hematopoietic Organs; Disorder Interventions: Radiation: Total lymphoid irradiation Sponsors: Hong Kong Children ' s Hospital; The University of Hong Kong; Hong Kong Sanatorium& Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 10, 2023 Category: Research Source Type: clinical trials
Multivirus-specific T Cells in the Treatment of Refractory CMV and/or EBV Infection After Allo-HSCT
Conditions: CMV Infection; EBV Infection; Stem Cell Transplant Interventions: Biological: Virus specific T cells Sponsors: Peking University People ' s Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 10, 2023 Category: Research Source Type: clinical trials
A Retrospective Study on the Relationship Between Donor Leukocyte Telomere Length and Prognosis of Acute Leukemia Patients Treated With Allogeneic Hematopoietic Stem Cell Transplantation
Conditions: Acute Leukemia Interventions: Other: No intervention, observation study Sponsors: Zhejiang University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 10, 2023 Category: Research Source Type: clinical trials
MAP-guided Preemptive Therapy of aGvHD by Ruxolitinib
Conditions: GVHD; Acute Stem Cell Transplant Complications Interventions: Drug: Ruxolitinib Sponsors: Sichuan University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 10, 2023 Category: Research Source Type: clinical trials
A Proof of Concept Study to Evaluate Exosomes From Human Mesenchymal Stem Cells in Women With Premature Ovarian Insufficiency (POI)
Conditions: Premature Ovarian Insufficiency; Diminished Ovarian Reserve Interventions: Drug: EV-Pure ™ Sponsors: Vitti Labs, LLC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 9, 2023 Category: Research Source Type: clinical trials
